Literature DB >> 23342181

Critical limb ischemia: advanced medical therapy.

Mark G Davies1.   

Abstract

Systemic atherosclerosis and its risk factors are present in the majority of patients with critical limb ischemia. Aggressive medical therapy is an immediate and necessary part of the work-up and management of these patients and will involve a multidisciplinary approach. Risk stratification based on a patient's current clinical cardiovascular condition is important in determining the most appropriate and safe intervention and will allow both the patient and physician to make an informed decision regarding risk- and cost-benefits of treatment.

Entities:  

Keywords:  atherosclerosis; critical limb ischemia; risk assessment; risk modification

Mesh：

Substances：

Year:  2012        PMID： 23342181      PMCID： PMC3549643          DOI： 10.14797/mdcj-8-4-3

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN： 1947-6108


  65 in total

1.  The practical management of claudication.

Authors:  A Davies
Journal:  BMJ       Date:  2000-10-14

2.  Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study.

Authors:  Joanne M Murabito; Jane C Evans; Kenneth Nieto; Martin G Larson; Daniel Levy; Peter W f Wilson
Journal:  Am Heart J       Date:  2002-06       Impact factor: 4.749

3.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

4.  2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis M Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette Kass Wenger; R Scott Wright; Sidney C Smith
Journal:  Circulation       Date:  2011-03-28       Impact factor: 29.690

5.  Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial.

Authors:  Michael S Conte; Dennis F Bandyk; Alexander W Clowes; Gregory L Moneta; Hamid Namini; Lynn Seely
Journal:  J Vasc Surg       Date:  2005-09       Impact factor: 4.268

6.  Controlled trial of high- versus low-dose aspirin treatment after percutaneous transluminal angioplasty in patients with peripheral vascular disease.

Authors:  C Ranke; A Creutzig; G Luska; H H Wagner; M Galanski; S Bode-Böger; J Frölich; H J Avenarius; H Hecker; K ALexander
Journal:  Clin Investig       Date:  1994-09

Review 7.  Nicotine receptor partial agonists for smoking cessation.

Authors:  Kate Cahill; Lindsay F Stead; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2011-02-16

8.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

Review 9.  Lipid-lowering for peripheral arterial disease of the lower limb.

Authors:  P P Aung; H G Maxwell; R G Jepson; J F Price; G C Leng
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

Review 10.  Nicotine replacement therapy for smoking cessation.

Authors:  L F Stead; R Perera; C Bullen; D Mant; T Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23
View more
  1 in total

Review 1.  Current Status of Arterial Revascularization for the Treatment of Critical Limb Ischemia in Infrainguinal Atherosclerotic Disease.

Authors:  Ahmet Yuksel; Yusuf Velioglu; Mustafa Cagdas Cayir; Gencehan Kumtepe; Orcun Gurbuz
Journal:  Int J Angiol       Date:  2018-01-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.